Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

High-flow nasal oxygen to prevent low oxygen during sedated endoscopy in people with high-risk sleep apnea

Official title: High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients: A Multicenter Randomized Trial

Run by Zhejiang University · NCT07307560 · Data updated 2026-11-12

This will test whether using high‑flow nasal oxygen instead of a regular nasal cannula prevents low oxygen levels during propofol‑sedated gastroscopy or colonoscopy in adults with high‑risk obstructive sleep apnea (STOP‑Bang ≥5).

More Hypoxia trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment600 (estimated)
SponsorZhejiang University
Academic / other
Locations3 sites (Hangzhou, Zhejiang and 2 other locations)
StatusRecruiting
StartedDecember 21, 2025
Main results expectedDecember 1, 2026
Study endsDecember 1, 2026
Registry record updatedMay 4, 2026
Trial IDNCT07307560 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with STOP‑Bang ≥5 who are scheduled for a propofol‑sedated gastroscopy or colonoscopy expected to last 45 minutes or less and who can give informed consent.

Probably not a fit

Patients with chronic lung disease requiring long‑term oxygen, preoperative SpO2 ≤92% on room air, severe organ dysfunction, active upper respiratory infection, bleeding risk, or those who are pregnant or breastfeeding are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter randomized controlled trial compares high‑flow nasal cannula (HFNC) with standard nasal cannula during propofol‑sedated gastrointestinal endoscopy in adults identified as high risk for OSA (STOP‑Bang ≥5). Eligible patients scheduled for gastroscopy, colonoscopy, or both, with procedures expected to last 45 minutes or less, will be randomized to receive HFNC or regular nasal oxygen during the procedure. The primary outcome is the occurrence of hypoxia (oxygen desaturation) during the procedure, with safety and adverse events also recorded. Major exclusions include active upper respiratory infection, chronic pulmonary disease requiring long‑term oxygen, preoperative SpO2 ≤92% on room air, severe organ dysfunction, coagulation disorders, pregnancy, or breastfeeding.

Why it matters

Potential benefit: If successful, HFNC could reduce episodes of oxygen desaturation during sedated endoscopy, making procedures safer for high‑risk OSA patients.

How similar studies have gone: Previous small or preliminary studies suggest HFNC can reduce hypoxemia during sedation, but evidence is limited and inconsistent specifically in high‑risk OSA populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years.
* STOP-Bang score ≥5.
* Scheduled for sedated gastrointestinal endoscopy (gastroscopy, colonoscopy, or combined gastroscopy + colonoscopy).
* The estimated duration of the procedure does not exceed 45 minutes.
* Patients have signed the informed consent form.

Exclusion Criteria:

* Coagulation disorders or bleeding tendency (e.g., oral/nasal bleeding risk, mucosal injury, space-occupying obstructions).
* Active upper respiratory tract infection (oral, nasal, or pharyngeal), or fever (core temperature \>37.5°C).
* Chronic obstructive pulmonary disease or other acute/chronic pulmonary diseases requiring long-term or intermittent oxygen therapy, or preoperative SpO₂ ≤ 92% on room air.
* Severe organ dysfunction, including: Cardiac insufficiency (\<4 METs), Severe renal insufficiency (requiring dialysis), Diagnosed severe hepatic insufficiency, Increased intracranial pressure, ASA physical status ≥ IV.
* Confirmed pregnancy or current breastfeeding.
* Known allergy to sedatives (e.g., propofol) or medical adhesives.
* Multiple traumatic injuries.
* Current participation in another clinical trial.
* Other conditions deemed unsuitable by the investigator

Where it's running

  • The First Affiliated Hospital, Zhejiang University School of Medicine
    Hangzhou, Zhejiang, China
    Recruiting
  • The First Hospital Of Jiaxing
    Jiaxing, Zhejiang, China
    Recruiting
  • Quzhou People's Hospital
    Quzhou, Zhejiang, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.